Company RedHill Biopharma Ltd TEL AVIV STOCK EXCHANGE
Equities
IL0011223810
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Commercial
100.0
%
| 62 | 100.0 % | 7 | 100.0 % | -89.43% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 62 | 100.0 % | 7 | 100.0 % | -89.43% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dror Ben-Asher
CEO | Chief Executive Officer | 59 | 03/09/03 |
Ori Shilo
FOU | Founder | 58 | 03/09/03 |
Razi Ingber
DFI | Director of Finance/CFO | - | 05/23/05 |
Gilead Raday
COO | Chief Operating Officer | 49 | 10/10/10 |
Ira N. Kalfus
CTO | Chief Tech/Sci/R&D Officer | 63 | - |
Reza Fathi
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/10/01 |
kristin Comer
CMP | Compliance Officer | - | - |
June Almenoff
CTO | Chief Tech/Sci/R&D Officer | 67 | 28/19/28 |
Mark L. Levitt
CTO | Chief Tech/Sci/R&D Officer | - | 01/17/01 |
Terry F. Plasse
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Rick Scruggs
BRD | Director/Board Member | 64 | 01/16/01 |
Shmuel Cabilly
BRD | Director/Board Member | 74 | 26/10/26 |
Director/Board Member | 80 | 03/10/03 | |
Alla Felder
BRD | Director/Board Member | 50 | 06/19/06 |
Dror Ben-Asher
CEO | Chief Executive Officer | 59 | 03/09/03 |
Kenneth Reed
BRD | Director/Board Member | 70 | 15/09/15 |
Ofer Tsimchi
BRD | Director/Board Member | 64 | 04/11/04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 7,869,853,000 | 7,791,154,470 ( 99.00 %) | 0 | 99.00 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-3.93% | 86.16B | |
+2.76% | 40.17B | |
-16.48% | 31.47B | |
+54.18% | 25.24B | |
-13.58% | 15.82B | |
-9.12% | 11.96B | |
-42.56% | 11.61B | |
+5.32% | 8.84B | |
-2.11% | 7.93B |